Update README.md
Browse files
README.md
CHANGED
@@ -44,7 +44,7 @@ Ready to enhance your platform with leading AI dermatology analytics?
|
|
44 |
Autoderm® AI technology meets EU standards for medical device safety and quality in dermatology, and complies with UK regulatory requirements. It has also received FDA Breakthrough Device Designation in the USA. 🇪🇺🇬🇧🇺🇸
|
45 |
|
46 |
> **Note:** In the USA, the product is not currently marketed and should only be used for demonstration with "test images", not on US residents.
|
47 |
-
|
48 |
> In the UK, [5% of malignant melanomas](https://www.htworld.co.uk/news/medtech/ai-powered-device-identifies-5-of-all-uk-melanoma-cases/) were detected in June 2024 via the [MyGP app using Autoderm's Scanner](https://autoderm.ai/blog/mygp_iplato_revolutionize_healthcare.html)
|
49 |
|
50 |
On Huggingface, we plan to release small-scale, easy-to-use models. For the most capable ones and to use our cloud capabilities, [sign up](https://autoderm.ai) today!
|
|
|
44 |
Autoderm® AI technology meets EU standards for medical device safety and quality in dermatology, and complies with UK regulatory requirements. It has also received FDA Breakthrough Device Designation in the USA. 🇪🇺🇬🇧🇺🇸
|
45 |
|
46 |
> **Note:** In the USA, the product is not currently marketed and should only be used for demonstration with "test images", not on US residents.
|
47 |
+
|
48 |
> In the UK, [5% of malignant melanomas](https://www.htworld.co.uk/news/medtech/ai-powered-device-identifies-5-of-all-uk-melanoma-cases/) were detected in June 2024 via the [MyGP app using Autoderm's Scanner](https://autoderm.ai/blog/mygp_iplato_revolutionize_healthcare.html)
|
49 |
|
50 |
On Huggingface, we plan to release small-scale, easy-to-use models. For the most capable ones and to use our cloud capabilities, [sign up](https://autoderm.ai) today!
|